Seronegative Intestinal Villous Atrophy: A Diagnostic Challenge

Celiac disease is the most important cause of intestinal villous atrophy. Seronegative intestinal villous atrophy, including those that are nonresponsive to a gluten-free diet, is a diagnostic challenge. In these cases, before establishing the diagnosis of seronegative celiac disease, alternative et...

Full description

Saved in:
Bibliographic Details
Main Authors: Cláudio Martins, Cristina Teixeira, Suzane Ribeiro, Daniel Trabulo, Cláudia Cardoso, João Mangualde, Ricardo Freire, Ana Luísa Alves, Élia Gamito, Isabelle Cremers, Ana Paula Oliveira
Format: Article
Language:English
Published: Wiley 2016-01-01
Series:Case Reports in Gastrointestinal Medicine
Online Access:http://dx.doi.org/10.1155/2016/6392028
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832564253468393472
author Cláudio Martins
Cristina Teixeira
Suzane Ribeiro
Daniel Trabulo
Cláudia Cardoso
João Mangualde
Ricardo Freire
Ana Luísa Alves
Élia Gamito
Isabelle Cremers
Ana Paula Oliveira
author_facet Cláudio Martins
Cristina Teixeira
Suzane Ribeiro
Daniel Trabulo
Cláudia Cardoso
João Mangualde
Ricardo Freire
Ana Luísa Alves
Élia Gamito
Isabelle Cremers
Ana Paula Oliveira
author_sort Cláudio Martins
collection DOAJ
description Celiac disease is the most important cause of intestinal villous atrophy. Seronegative intestinal villous atrophy, including those that are nonresponsive to a gluten-free diet, is a diagnostic challenge. In these cases, before establishing the diagnosis of seronegative celiac disease, alternative etiologies of atrophic enteropathy should be considered. Recently, a new clinical entity responsible for seronegative villous atrophy was described—olmesartan-induced sprue-like enteropathy. Herein, we report two uncommon cases of atrophic enteropathy in patients with arterial hypertension under olmesartan, who presented with severe chronic diarrhea and significant involuntary weight loss. Further investigation revealed intestinal villous atrophy and intraepithelial lymphocytosis. Celiac disease and other causes of villous atrophy were ruled out. Drug-induced enteropathy was suspected and clinical improvement and histologic recovery were verified after olmesartan withdrawal. These cases highlight the importance for clinicians to maintain a high index of suspicion for olmesartan as a precipitant of sprue-like enteropathy.
format Article
id doaj-art-33643b42c7b944ea85e45cab174a8445
institution Kabale University
issn 2090-6528
2090-6536
language English
publishDate 2016-01-01
publisher Wiley
record_format Article
series Case Reports in Gastrointestinal Medicine
spelling doaj-art-33643b42c7b944ea85e45cab174a84452025-02-03T01:11:29ZengWileyCase Reports in Gastrointestinal Medicine2090-65282090-65362016-01-01201610.1155/2016/63920286392028Seronegative Intestinal Villous Atrophy: A Diagnostic ChallengeCláudio Martins0Cristina Teixeira1Suzane Ribeiro2Daniel Trabulo3Cláudia Cardoso4João Mangualde5Ricardo Freire6Ana Luísa Alves7Élia Gamito8Isabelle Cremers9Ana Paula Oliveira10Department of Gastroenterology, Setúbal Hospital Center, São Bernardo Hospital, Setúbal, PortugalDepartment of Gastroenterology, Setúbal Hospital Center, São Bernardo Hospital, Setúbal, PortugalDepartment of Gastroenterology, Setúbal Hospital Center, São Bernardo Hospital, Setúbal, PortugalDepartment of Gastroenterology, Setúbal Hospital Center, São Bernardo Hospital, Setúbal, PortugalDepartment of Gastroenterology, Setúbal Hospital Center, São Bernardo Hospital, Setúbal, PortugalDepartment of Gastroenterology, Setúbal Hospital Center, São Bernardo Hospital, Setúbal, PortugalDepartment of Gastroenterology, Setúbal Hospital Center, São Bernardo Hospital, Setúbal, PortugalDepartment of Gastroenterology, Setúbal Hospital Center, São Bernardo Hospital, Setúbal, PortugalDepartment of Gastroenterology, Setúbal Hospital Center, São Bernardo Hospital, Setúbal, PortugalDepartment of Gastroenterology, Setúbal Hospital Center, São Bernardo Hospital, Setúbal, PortugalDepartment of Gastroenterology, Setúbal Hospital Center, São Bernardo Hospital, Setúbal, PortugalCeliac disease is the most important cause of intestinal villous atrophy. Seronegative intestinal villous atrophy, including those that are nonresponsive to a gluten-free diet, is a diagnostic challenge. In these cases, before establishing the diagnosis of seronegative celiac disease, alternative etiologies of atrophic enteropathy should be considered. Recently, a new clinical entity responsible for seronegative villous atrophy was described—olmesartan-induced sprue-like enteropathy. Herein, we report two uncommon cases of atrophic enteropathy in patients with arterial hypertension under olmesartan, who presented with severe chronic diarrhea and significant involuntary weight loss. Further investigation revealed intestinal villous atrophy and intraepithelial lymphocytosis. Celiac disease and other causes of villous atrophy were ruled out. Drug-induced enteropathy was suspected and clinical improvement and histologic recovery were verified after olmesartan withdrawal. These cases highlight the importance for clinicians to maintain a high index of suspicion for olmesartan as a precipitant of sprue-like enteropathy.http://dx.doi.org/10.1155/2016/6392028
spellingShingle Cláudio Martins
Cristina Teixeira
Suzane Ribeiro
Daniel Trabulo
Cláudia Cardoso
João Mangualde
Ricardo Freire
Ana Luísa Alves
Élia Gamito
Isabelle Cremers
Ana Paula Oliveira
Seronegative Intestinal Villous Atrophy: A Diagnostic Challenge
Case Reports in Gastrointestinal Medicine
title Seronegative Intestinal Villous Atrophy: A Diagnostic Challenge
title_full Seronegative Intestinal Villous Atrophy: A Diagnostic Challenge
title_fullStr Seronegative Intestinal Villous Atrophy: A Diagnostic Challenge
title_full_unstemmed Seronegative Intestinal Villous Atrophy: A Diagnostic Challenge
title_short Seronegative Intestinal Villous Atrophy: A Diagnostic Challenge
title_sort seronegative intestinal villous atrophy a diagnostic challenge
url http://dx.doi.org/10.1155/2016/6392028
work_keys_str_mv AT claudiomartins seronegativeintestinalvillousatrophyadiagnosticchallenge
AT cristinateixeira seronegativeintestinalvillousatrophyadiagnosticchallenge
AT suzaneribeiro seronegativeintestinalvillousatrophyadiagnosticchallenge
AT danieltrabulo seronegativeintestinalvillousatrophyadiagnosticchallenge
AT claudiacardoso seronegativeintestinalvillousatrophyadiagnosticchallenge
AT joaomangualde seronegativeintestinalvillousatrophyadiagnosticchallenge
AT ricardofreire seronegativeintestinalvillousatrophyadiagnosticchallenge
AT analuisaalves seronegativeintestinalvillousatrophyadiagnosticchallenge
AT eliagamito seronegativeintestinalvillousatrophyadiagnosticchallenge
AT isabellecremers seronegativeintestinalvillousatrophyadiagnosticchallenge
AT anapaulaoliveira seronegativeintestinalvillousatrophyadiagnosticchallenge